Evidence map›Paper›PMID 39283948›Full record

ArticlePLoS pathogens2024

Repeat modules and N-linked glycans define structure and antigenicity of a critical enterotoxigenic E. coli adhesin.

Zachary T Berndsen, Marjahan Akhtar, Mahima Thapa, Tim J Vickers, Aaron Schmitz, Jonathan L Torres, Sabyasachi Baboo, Pardeep Kumar, Nazia Khatoon, Alaullah Sheikh and 13 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Zachary T BerndsenDepartment of Integrative Structural and Computational Biology, Scripps Research, La Jolla, California, United States of America.ORCID 0000-0003-4531-9907
Marjahan AkhtarDepartment of Medicine, Division of Infectious Diseases, Washington University in Saint Louis, School of Medicine. Saint Louis, Missouri, United States of America.
Mahima ThapaDepartment of Pathology and Immunology, Washington University in Saint Louis, School of Medicine, Saint Louis, Missouri, United States of America.
Tim J VickersDepartment of Medicine, Division of Infectious Diseases, Washington University in Saint Louis, School of Medicine. Saint Louis, Missouri, United States of America.
Aaron SchmitzDepartment of Pathology and Immunology, Washington University in Saint Louis, School of Medicine, Saint Louis, Missouri, United States of America.
Jonathan L TorresDepartment of Integrative Structural and Computational Biology, Scripps Research, La Jolla, California, United States of America.
Sabyasachi BabooDepartment of Molecular Medicine, The Scripps Research Institute, La Jolla, California, United States of America.
Pardeep KumarDepartment of Medicine, Division of Infectious Diseases, Washington University in Saint Louis, School of Medicine. Saint Louis, Missouri, United States of America.
Nazia KhatoonDepartment of Medicine, Division of Infectious Diseases, Washington University in Saint Louis, School of Medicine. Saint Louis, Missouri, United States of America.
Alaullah SheikhDepartment of Medicine, Division of Infectious Diseases, Washington University in Saint Louis, School of Medicine. Saint Louis, Missouri, United States of America.
Melissa HamrickDepartment of Medicine, Division of Infectious Diseases, Washington University in Saint Louis, School of Medicine. Saint Louis, Missouri, United States of America.
Jolene K DiedrichDepartment of Molecular Medicine, The Scripps Research Institute, La Jolla, California, United States of America.
Salvador Martinez-BartolomeDepartment of Molecular Medicine, The Scripps Research Institute, La Jolla, California, United States of America.
Patrick T GarrettDepartment of Molecular Medicine, The Scripps Research Institute, La Jolla, California, United States of America.
John R YatesDepartment of Molecular Medicine, The Scripps Research Institute, La Jolla, California, United States of America.
Jackson S TurnerDepartment of Pathology and Immunology, Washington University in Saint Louis, School of Medicine, Saint Louis, Missouri, United States of America.
Renee M LairdOperationally Relevant Infections Department, Naval Medical Research Command (NMRC), Silver Spring, Maryland, United States of America.
Frédéric PolyOperationally Relevant Infections Department, Naval Medical Research Command (NMRC), Silver Spring, Maryland, United States of America.
Chad K PorterTranslational and Clinical Research Department, Naval Medical Research Command (NMRC), Silver Spring, Maryland, United States of America.
Jeffrey CoppsDepartment of Integrative Structural and Computational Biology, Scripps Research, La Jolla, California, United States of America.
Ali H EllebedyDepartment of Pathology and Immunology, Washington University in Saint Louis, School of Medicine, Saint Louis, Missouri, United States of America.
Andrew B WardDepartment of Integrative Structural and Computational Biology, Scripps Research, La Jolla, California, United States of America.
James M FleckensteinDepartment of Medicine, Division of Infectious Diseases, Washington University in Saint Louis, School of Medicine. Saint Louis, Missouri, United States of America.ORCID 0000-0002-1148-697X

Funding

Infectious Diseases/Basic Microbial Pathogenic MechanismsT32AI007172 · NIAID · WASHINGTON UNIVERSITY · PI Daniel E. Goldberg, JENNIFER A PHILIPS · 1985 to 2026
$13.0M
Novel Antigen Identification for an Enterotoxigenic E. coli VaccineR01AI089894 · NIAID · WASHINGTON UNIVERSITY · PI Zachary T. Berndsen, James Michael Fleckenstein · 2010 to 2026
$7.4M
Molecular Pathogenesis of enterotoxigenic E. coli associated enteropathyR01AI170949 · NIAID · WASHINGTON UNIVERSITY · PI James Michael Fleckenstein · 2023 to 2026
$2.4M
Molecular Microbiology of Enterotoxigenic E. coli Pathogen-Host InteractionsR01AI126887 · NIAID · WASHINGTON UNIVERSITY · PI FLECKENSTEIN, JAMES MICHAEL · 2016 to 2020
$1.6M
Molecular Pathogenesis of Enterotoxigenic Escherichia coli InfectionsI01BX001469 · VA · ST. LOUIS VA MEDICAL CENTER · PI FLECKENSTEIN, JAMES MICHAEL · 2013 to 2017
–
BLRD VA I01 BX001469BLRD VA I01 BX004825NIAID NIH HHS R01 AI089894NIAID NIH HHS R01 AI126887NIAID NIH HHS R01 AI170949NIAID NIH HHS T32 AI007172
6 · The paper itself

Abstract

Enterotoxigenic Escherichia coli (ETEC) cause hundreds of millions of cases of infectious diarrhea annually, predominantly in children from low-middle income regions. Notably, in children, as well as volunteers challenged with ETEC, diarrheal severity is significantly increased in blood group A (bgA) individuals. EtpA, is a secreted glycoprotein adhesin that functions as a blood group A lectin to promote critical interactions between ETEC and blood group A glycans on intestinal epithelia for effective bacterial adhesion and toxin delivery. EtpA is highly immunogenic resulting in robust antibody responses following natural infection and experimental challenge of volunteers with ETEC. To understand how EtpA directs ETEC-blood group A interactions and stimulates adaptive immunity, we mutated EtpA, mapped its glycosylation by mass-spectrometry (MS), isolated polyclonal (pAbs) and monoclonal antibodies (mAbs) from vaccinated mice and ETEC-infected volunteers, and determined structures of antibody-EtpA complexes by cryo-electron microscopy. Both bgA and mAbs that inhibited EtpA-bgA interactions and ETEC adhesion, bound to the C-terminal repeat domain highlighting this region as crucial for ETEC pathogen-host interaction. MS analysis uncovered extensive and heterogeneous N-linked glycosylation of EtpA and cryo-EM structures revealed that mAbs directly engage these unique glycan containing epitopes. Finally, electron microscopy-based polyclonal epitope mapping revealed antibodies targeting numerous distinct epitopes on N and C-terminal domains, suggesting that EtpA vaccination generates responses against neutralizing and decoy regions of the molecule. Collectively, we anticipate that these data will inform our general understanding of pathogen-host glycan interactions and adaptive immunity relevant to rational vaccine subunit design.

Indexed as

Enterotoxigenic Escherichia coliEscherichia coli InfectionsEscherichia coli ProteinsPolysaccharidesAdhesins, Escherichia coliAnimalsAntibodies, BacterialBacterial AdhesionGlycosylationHumansMembrane GlycoproteinsMiceAdhesins, Escherichia coliAntibodies, BacterialEscherichia coli ProteinsEtpA protein, E coliMembrane GlycoproteinsPolysaccharides

Identifiers

PMID39283948
PMCPMC11463764

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.